These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21287169)

  • 1. Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease.
    Isozaki M; Kiyono Y; Arai Y; Kudo T; Mori T; Maruyama R; Kikuta K; Okazawa H
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1075-82. PubMed ID: 21287169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of misery perfusion in the cerebral hemisphere with chronic unilateral major cerebral artery steno-occlusive disease using crossed cerebellar hypoperfusion: comparison of brain SPECT and PET imaging.
    Matsumoto Y; Ogasawara K; Saito H; Terasaki K; Takahashi Y; Ogasawara Y; Kobayashi M; Yoshida K; Beppu T; Kubo Y; Fujiwara S; Tsushima E; Ogawa A
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1573-81. PubMed ID: 23740375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer.
    Lohith TG; Kudo T; Demura Y; Umeda Y; Kiyono Y; Fujibayashi Y; Okazawa H
    J Nucl Med; 2009 Dec; 50(12):1948-53. PubMed ID: 19910425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.
    Kuroda H; Ogasawara K; Suzuki T; Chida K; Aso K; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Kubo Y; Ogawa A
    Clin Nucl Med; 2012 Mar; 37(3):235-40. PubMed ID: 22310248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.
    Zhang T; Das SK; Fels DR; Hansen KS; Wong TZ; Dewhirst MW; Vlahovic G
    AJR Am J Roentgenol; 2013 Nov; 201(5):W698-706. PubMed ID: 24147499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?
    Okazawa H; Tsuchida T; Kobayashi M; Arai Y; Pagani M; Isozaki M; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):121-9. PubMed ID: 16896662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misery perfusion and amyloid deposition in atherosclerotic major cerebral artery disease.
    Yamauchi H; Kagawa S; Takahashi M; Oishi N; Ono M; Higashi T
    Neuroimage Clin; 2019; 22():101762. PubMed ID: 30884364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
    Yuan H; Schroeder T; Bowsher JE; Hedlund LW; Wong T; Dewhirst MW
    J Nucl Med; 2006 Jun; 47(6):989-98. PubMed ID: 16741309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease.
    Chida K; Ogasawara K; Kuroda H; Aso K; Kobayashi M; Fujiwara S; Yoshida K; Terasaki K; Ogawa A
    J Nucl Med; 2011 Apr; 52(4):511-8. PubMed ID: 21421729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of
    Toriihara A; Ohtake M; Tateishi K; Hino-Shishikura A; Yoneyama T; Kitazume Y; Inoue T; Kawahara N; Tateishi U
    Ann Nucl Med; 2018 May; 32(4):264-271. PubMed ID: 29453680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET measurements of CBF, OEF, and CMRO2 without arterial sampling in hyperacute ischemic stroke: method and error analysis.
    Ibaraki M; Shimosegawa E; Miura S; Takahashi K; Ito H; Kanno I; Hatazawa J
    Ann Nucl Med; 2004 Feb; 18(1):35-44. PubMed ID: 15072182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET.
    Ikawa M; Okazawa H; Kudo T; Kuriyama M; Fujibayashi Y; Yoneda M
    Nucl Med Biol; 2011 Oct; 38(7):945-51. PubMed ID: 21982566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
    Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
    J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Day-to-day test-retest variability of CBF, CMRO2, and OEF measurements using dynamic 15O PET studies.
    Bremmer JP; van Berckel BN; Persoon S; Kappelle LJ; Lammertsma AA; Kloet R; Luurtsema G; Rijbroek A; Klijn CJ; Boellaard R
    Mol Imaging Biol; 2011 Aug; 13(4):759-68. PubMed ID: 20700768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.
    Fletcher JW; Logan TF; Eitel JA; Mathias CJ; Ng Y; Lacy JL; Hutchins GD; Green MA
    J Nucl Med; 2015 Jan; 56(1):56-62. PubMed ID: 25525184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.
    Wong TZ; Lacy JL; Petry NA; Hawk TC; Sporn TA; Dewhirst MW; Vlahovic G
    AJR Am J Roentgenol; 2008 Feb; 190(2):427-32. PubMed ID: 18212229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma.
    Tateishi K; Tateishi U; Sato M; Yamanaka S; Kanno H; Murata H; Inoue T; Kawahara N
    AJNR Am J Neuroradiol; 2013 Jan; 34(1):92-9. PubMed ID: 22700754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality functional imaging of spontaneous canine tumors using 64Cu-ATSM and 18FDG PET/CT and dynamic contrast enhanced perfusion CT.
    Hansen AE; Kristensen AT; Law I; McEvoy FJ; Kjær A; Engelholm SA
    Radiother Oncol; 2012 Mar; 102(3):424-8. PubMed ID: 22119225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox reaction and clinical outcome of primary diffuse large B-cell lymphoma of the central nervous system: Prognostic role of metabolic and textural parameters of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/computed tomography in a small patient cohort.
    Tsuchiya J; Yoneyama T; Ohtake M; Tateishi K; Bae H; Kishino M; Tateishi U
    Nucl Med Commun; 2020 Jun; 41(6):567-574. PubMed ID: 32371672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.
    Chao KS; Bosch WR; Mutic S; Lewis JS; Dehdashti F; Mintun MA; Dempsey JF; Perez CA; Purdy JA; Welch MJ
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1171-82. PubMed ID: 11240261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.